Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Bicara Therapeutics shows potential to reshape cancer care with ficerafusp alfa and robust funding post-IPO. Find out why ...

Terpenes, derived from the Cannabis sativa plant, may be the basis of a medication for fibromyalgia and post-surgical pain ...

Patients are growing increasingly interested in medical marijuana. As this interest grows, dermatologists must be prepared to ...

With a watery consistency, this formula is tops at providing weightless hydration that won't leave behind an unflattering ...

Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune ...

What to look for: Most studies on OTC niacinamide used formulas with 2 to 5 percent concentrations, and research shows that ...

Perspective Therapeutics, Inc.’s CATX share price has dipped by 5.02%, which has investors questioning if this is right time ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

Latest study leverages new constructs for nuclear localization signal (NLS) sequences to improve editing efficiency in human ...